Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual,CA: A Cancer Journal for Clinicians

当前位置： X-MOL 学术 › CA: Cancer J. Clin. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual
CA: A Cancer Journal for Clinicians ( IF 254.7 ) Pub Date : 2017-10-13 , DOI: 10.3322/caac.21409
Jeffrey E Gershenwald ₁ , Richard A Scolyer _{2,

3} , Kenneth R Hess ₄ , Vernon K Sondak ₅ , Georgina V Long ₆ , Merrick I Ross ₇ , Alexander J Lazar ₈ , Mark B Faries ₉ , John M Kirkwood ₁₀ , Grant A McArthur ₁₁ , Lauren E Haydu ₁₂ , Alexander M M Eggermont ₁₃ , Keith T Flaherty ₁₄ , Charles M Balch ₁₅ , John F Thompson ₁₆ ,

Affiliation

Professor of Surgery and Cancer Biology, Department of Surgical Oncology; Medical Director, Melanoma and Skin Center, The University of Texas MD Anderson Cancer Center, Houston, TX.
Conjoint Medical Director, Melanoma Institute Australia; Clinical Professor, The University of Sydney, Sydney, New South Wales, Australia.
Senior Staff Pathologist, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
Professor, Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX.
Chair, Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL.
Conjoint Medical Director and Chair of Melanoma Medical Oncology and Translational Research, Melanoma Institute Australia, The University of Sydney and Royal North Shore Hospital, Sydney, New South Wales, Australia.
Professor of Surgery, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Professor of Pathology, Dermatology, and Translational Molecular Pathology; Director, Melanoma Molecular Diagnostics, The University of Texas MD Anderson Cancer Center, Houston, TX.
Co-Director, Melanoma Program; Head, Surgical Oncology, The Angeles Clinic and Research Institute, Los Angeles, CA.
Professor of Medicine, Dermatology, and Translational Science, The University of Pittsburgh School of Medicine, Pittsburgh, PA.
Executive Director, Victorian Comprehensive Cancer Center, Melbourne, Victoria, Australia.
Manager, Clinical Data Management Systems, The University of Texas MD Anderson Cancer Center, Houston, TX.
Director General, Gustave Roussy Cancer Institute, Villejuif, France.
Director, Termeer Center for Targeted Therapy, Massachusetts General Hospital Cancer Center, Boston, MA.
Professor of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX.
Professor of Melanoma and Surgical Oncology, Melanoma Institute Australia, The University of Sydney and Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.